Advantage Alpha Capital Partners’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,292
Closed -$438K 161
2024
Q3
$438K Buy
+8,292
New +$438K 0.1% 146